ProSciento, Inc.’s Post

📢 Are you part of the #Type1Diabetes community? Your voice is crucial in determining the future of diabetes research. Take a moment to complete the Diabetes Collaborative Clinical Trial Network's research priorities shortlisting survey: https://lnkd.in/dsX4T5Fv. #DiabetesResearch #ResearchPriorities #diabetes #T1D #diabetescommunity #psp

📢 Are you part of the #Type1Diabetes community? Your voice is crucial in determining the future of diabetes research. Take a moment to complete the Diabetes Collaborative Clinical Trial Network Research Priorities Ranking Survey using the QR or the link https://lnkd.in/dsX4T5Fv. Let's work together to prioritize what matters most for our community's future. #DiabetesResearch #ResearchPriorities #diabetes #T1D #diabetescommunity   

As a health care professional, you are driven by the same motivation as we are: improving patient lives. October is National Liver Awareness Month and an important opportunity to acknowledge the many challenges patients with liver disease face on a daily basis. We are proud to offer this informative resource to physicians regarding treatment options and why earlier transjugular intrahepatic portosystemic shunt (TIPS) creation can increase survival in high-risk liver disease patients (references 1, 2): https://brnw.ch/21wDYTE For indications and to learn more: https://lnkd.in/et2_naiG #GoreMedical #NationalLiverAwarenessMonth ______________________________________________________________________ Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available.   Approved for use in the U.S.

Clinical trials are vital to developing treatments for the millions of people worldwide suffering from rare diseases, but trials for these diseases are complicated by the vast geographical differences between patients. With the spencer SmartHub™, clinical teams can monitor a patient's trial experience no matter how far away their patient lives with the help of the patient's in-home trial partner, spencer®. spencer is a platform that achieves 97% medication adherence, engages daily with the patient through customizable surveys, and collects RWD directly from a patient's countertop. With solutions like spencer, treatments for the over 10,000 rare diseases known globally are one step closer to reality. 🌎 Learn more about how spencer supports clinical research: https://hubs.li/Q02mFNT90 #RareDiseaseDay #ClinicalTrials #RareDiseaseClinicalTrials

🚨 Important Research Update from the #DiabetesCare–CDC Symposium! We are pleased to share a new article titled "Trends and Inequalities in Diabetes-Related Complications Among U.S. Adults, 2000–2020." Co-authored by EGDRC’s  Francisco J. Pasquel and a team of distinguished researchers, this study provides an in-depth analysis of national trends in diabetes-related complications such as heart failure, stroke, and end-stage renal disease. This research highlights critical areas for intervention to reduce disparities and improve outcomes in diabetes care. Read more at: https://lnkd.in/eh6-Fesg #DiabetesCare #PublicHealth #HealthInequalities #CDC #HealthcareResearch

#UCalgary researchers, led by Drs. Pietro Ravani, MD, PhD, and Ping Liu, PhD, are now able to predict kidney failure more accurately. A digital tool created by a team of University of Calgary scientists and international research partners is poised to become the new standard for predicting the risks of kidney failure and death in adults with moderate-to-severe kidney disease. The Kidney Foundation of Canada estimates that one in 10 Canadians have chronic kidney disease and the number of Canadians living with end-stage kidney disease is also increasing, up 35 per cent since 2009. Dr. Liu says the tool’s ability to more accurately predict the risk of kidney failure, and the likelihood of death from it, can improve treatment. Read the full story below. O'Brien Institute for Public Health | Libin Cardiovascular Institute | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | UCalgary Centre for Health Informatics | #ResearchMatters

Seeking Research Partners to Deepen our Understanding of the Impact of Inflammatory Bowel Disease (IBD) on Daily Life Crohn's & Colitis UK is actively searching for research partners to enhance our understanding of how living with Inflammatory Bowel Disease (IBD) impacts various aspects of life. This project entails a comprehensive review of publicly available IBD data, the development of methodologies for constructing quality of life metrics and indicators, and survey design to effectively capture new data. These findings will play a pivotal role in creating a public-facing Quality of Life Dashboard to accurately represent the lived experience of individuals with Crohn’s and Colitis by presenting key health and non-health factors significantly affecting our community. The primary goal of the Dashboard is provide a visual representation of impact on quality of life for those living with IBD, based on the priorities of those living with the conditions, using metrics which illustrate improvement or deterioration in quality of life over time. For further details on this tender and how to submit a proposal, click here: https://ow.ly/Gt3a50QyHpA.. #Crohns #Colitis #IBD

Enroll now for the Practical Strategies for Applying Evidence and Patient Perspectives to Improve Obesity Management program, hosted by Clinical Care Options and supported by Eli Lilly and Company! Expert faculty discuss strategies to improve the treatment of obesity, including reducing the risk of complications, individualizing treatment plans, and engaging patients in successful long-term weight loss. Learn more at https://bit.ly/3RtDVdW. #Obesity #ObesityTreatment #ObesityManagement

Researchers at the University of Calgary, led by Drs. Pietro Ravani and Ping Liu, have developed KDpredict, a digital tool that advances how medical professionals predict kidney failure and mortality risks in chronic kidney disease (CKD) patients. Utilizing data from nearly 100,000 patients, KDpredict offers more accurate risk evaluations, aiding in the formulation of effective treatment strategies. This tool also considers comorbid conditions such as diabetes and heart disease, supporting personalized patient care. Read the full story at https://lnkd.in/gZ6RzTx9 Cumming School of Medicine UCalgary #UCalgary #UCalgaryMed #LibinInstitute #kidneydisease #chronickidneydisease #kidneyfailure #precisonmedicine

🔬 Exploring GERD: Understanding Gastroesophageal Reflux Disease 🔬 At MedTraits NY, we're dedicated to shedding light on common medical conditions to empower our community with knowledge and understanding. Today, let's delve into Gastroesophageal Reflux Disease (GERD). GERD occurs when stomach acid regularly flows back into the esophagus, causing discomfort and potentially leading to complications if left untreated. From heartburn and regurgitation to chest pain and difficulty swallowing, GERD symptoms can significantly impact one's quality of life. Our clinical research team at MedTraits NY is committed to advancing the understanding and treatment of GERD through innovative research initiatives. By collaborating with leading experts and employing state-of-the-art methodologies, we strive to enhance therapeutic options and improve patient outcomes. #MedTraitsNY #ClinicalResearch #GERD #HealthcareInnovation #empoweringcommunities